Trial Profile
Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2022
Price :
$35
*
At a glance
- Drugs Estradiol (Primary) ; Progesterone (Primary)
- Indications Menopausal syndrome; Suicidal ideation
- Focus Therapeutic Use
- Acronyms CLEAR-2
- 21 Apr 2022 Status changed from active, no longer recruiting to completed.
- 03 Mar 2021 Planned End Date changed from 1 Apr 2021 to 1 Jun 2021.
- 03 Mar 2021 Planned primary completion date changed from 1 Apr 2021 to 1 Jun 2021.